Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated Vasculitis

Journal of the American Society of Nephrology : JASN
Anna BertramTorsten Kirsch

Abstract

ANCA-associated vasculitides are characterized by inflammatory destruction of small vessels accompanied by enhanced cleavage of membrane-bound proteins. One of the main proteases responsible for ectodomain shedding is disintegrin and metalloproteinase domain-containing protein 17 (ADAM17). Given its potential role in aggravating vascular dysfunction, we examined the role of ADAM17 in active proteinase-3 (PR3)-positive ANCA-associated vasculitis (AAV). ADAM17 concentration was significantly increased in plasma samples from patients with active PR3-AAV compared with samples from patients in remission or from other controls with renal nonvascular diseases. Comparably, plasma levels of the ADAM17 substrate syndecan-1 were significantly enhanced in active AAV. We also observed that plasma-derived ADAM17 retained its specific proteolytic activity and was partly located on extracellular microparticles. Transcript levels of ADAM17 were increased in blood samples of patients with active AAV, but those of ADAM10 or tissue inhibitor of metalloproteinases 3, which inhibits ADAMs, were not. We also performed a microRNA (miR) screen and identified miR-634 as significantly upregulated in blood samples from patients with active AAV. In vitro, ...Continue Reading

References

Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Nov 20, 1997·The New England Journal of Medicine·J C Jennette, R J Falk
Jul 29, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·V TesarR Becvár
Feb 7, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J AraA Darnell
Mar 20, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·O JónasdóttirK Bendtzen
Aug 28, 2004·Journal of Leukocyte Biology·André P van RossumCees G M Kallenberg
Mar 19, 2005·Circulation Research·Eugene TkachenkoMichael Simons
Oct 3, 2006·Experimental Cell Research·Edwige TellierFranck Peiretti
Apr 27, 2007·Nature·Joseph R BishopJeffrey D Esko
Oct 7, 2008·Nature Medicine·Renate KainDontscho Kerjaschki
Oct 18, 2008·Rheumatology·U ErdbrueggerM Haubitz
Jun 19, 2009·American Journal of Physiology. Renal Physiology·W B MelenhorstH van Goor
Jan 27, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Estela NogueiraAlan D Salama
Jan 5, 2011·European Journal of Cell Biology·Paul Saftig, Karina Reiss
Mar 18, 2011·The Journal of Rheumatology·Gunnar TomassonUNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Jul 15, 2011·Trends in Immunology·Jürgen SchellerStefan Rose-John
Oct 25, 2011·Journal of the American Society of Nephrology : JASN·Aleeza J RothRonald J Falk
Oct 29, 2011·Journal of the American Society of Nephrology : JASN·Sandrine Le RouxFadi Fakhouri
Nov 5, 2011·Journal of the American Society of Nephrology : JASN·Ying HongPaul A Brogan
Dec 6, 2011·European Journal of Cell Biology·Daniela DreymuellerAndreas Ludwig
Feb 27, 2013·Neoplasia : an International Journal for Oncology Research·Kai DobersteinPaul Gutwein
Aug 31, 2014·Immunology Letters·Sabrina LisiMargherita Sisto

❮ Previous
Next ❯

Citations

Mar 17, 2016·World Journal of Nephrology·Alexandra Helmke, Sibylle von Vietinghoff
Dec 8, 2017·Nature Reviews. Rheumatology·Masayuki Nishide, Atsushi Kumanogoh
Nov 6, 2018·Molecular Human Reproduction·Katharina ProestlingLorenz Kuessel
Jul 9, 2017·Journal of the American Society of Nephrology : JASN·Mira ChoiRalph Kettritz
May 30, 2019·American Journal of Physiology. Renal Physiology·Vanesa PalauMarta Riera
Aug 16, 2018·Nature Reviews. Rheumatology·Mark McClureRachel Jones
Jun 19, 2019·Cellular and Molecular Life Sciences : CMLS·Franka ScharfenbergChristoph Becker-Pauly
Aug 14, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vanesa PalauMaria José Soler
Apr 2, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yang WangFang Zheng
Oct 8, 2020·International Journal of Molecular Sciences·Andreas KronbichlerJae Il Shin
Jun 8, 2021·Heliyon·Rachelle MendozaDimitar B Nikolov
Jul 3, 2021·Diagnostics·Yanjun ZhouStefanie Maurer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2021 Meta ULC. All rights reserved